CDMO Tedor Pharma recapitalizes following multi-million dollar investment
The newly-formed investment firm DORA Ventures has recapitalized Tedor Pharma, which recently completed a multi-million-dollar expansion of its manufacturing capabilities.
Archives for May 17, 2018
FDA issues final guidance in effort to protect clinical trial participants
The FDA has published a final guidance today in its efforts to improve protection for participants in clinical trials and reduce regulatory burden.
BioCity-backed CROs target biotech, mid-sized pharma customers in new discovery alliance
XenoGesis and BioAscent have teamed up to fill "a gap in the market" for integrated drug discovery services aimed at biotech, mid-sized pharma, and academic drug developers, says CEO.
Motif Bio secures £10m to support antibiotic commercialization efforts
Motif Bio plc has secured £10m ($14m) to support the potential commercialization of its lead candidate – iclaprim – which was granted FDA fast-track status in 2015.
US FDA import alert and warning for Indian API maker
The US FDA has cited cleaning validation and electronic data access concerns in its warning letter to Indian API maker Reine Lifesciences.
INTERPHEX 2018
Excipient makers want to be the ‘first second’ in novel ingredient development, say execs
An improved relationship between drugmakers and excipient suppliers could help drive development in the novel inactive ingredient sector, says industry expert.